| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10072-011-0552-1 |
| P698 | PubMed publication ID | 21533717 |
| P50 | author | Alberto Raggi | Q37830338 |
| Licia Grazzi | Q42702480 | ||
| Domenico D'Amico | Q51846705 | ||
| Gennaro Bussone | Q78768461 | ||
| P2093 | author name string | M Leonardi | |
| S Usai | |||
| P2860 | cites work | Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases | Q33946584 |
| New appendix criteria open for a broader concept of chronic migraine | Q34523930 | ||
| The global burden of headache: a documentation of headache prevalence and disability worldwide | Q34611721 | ||
| Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials. | Q34619560 | ||
| New paradigms in the recognition and acute treatment of migraine | Q34634345 | ||
| Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate | Q34976043 | ||
| CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review | Q35576922 | ||
| The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials | Q36168171 | ||
| The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). | Q36261290 | ||
| Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life | Q36356554 | ||
| Medication-overuse headache: description, treatment, and relapse prevention | Q36405693 | ||
| Treatment strategies in the acute therapy of migraine: stratified care and early intervention | Q36475022 | ||
| Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life | Q39803883 | ||
| Disability in chronic migraine with medication overuse: treatment effects through 5 years | Q42627933 | ||
| Botulinum toxin type A and acute drug costs in migraine with triptan overuse | Q42681242 | ||
| Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers | Q43158620 | ||
| Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial | Q46910225 | ||
| Quality of life and disability in primary chronic daily headaches. | Q47824944 | ||
| Kaplan Award 1998. Epidemiology of chronic daily headache in the general population | Q48345830 | ||
| Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center | Q48779169 | ||
| Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study | Q48960051 | ||
| Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. | Q51120904 | ||
| Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. | Q51756573 | ||
| World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation. | Q51872611 | ||
| Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. | Q51948254 | ||
| Quality-of-life differences between patients with episodic and transformed migraine. | Q51965402 | ||
| MIDAS and HIT-6 French translation: reliability and correlation between tests. | Q53029476 | ||
| Factors associated with burden of primary headache in a specialty clinic. | Q53300953 | ||
| A six-item short-form survey for measuring headache impact: the HIT-6. | Q53363511 | ||
| The definition of disability: what is in a name? | Q60460401 | ||
| Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy | Q62692714 | ||
| Disability Pattern in Chronic Migraine With Medication Overuse: A Comparison With Migraine Without Aura | Q62692818 | ||
| Disability and quality of life in different primary headaches: results from Italian studies | Q62692873 | ||
| Disability in Chronic Migraine Patients With Medication Overuse: Treatment Effects at 1-Year Follow-up | Q62692880 | ||
| Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society | Q70213757 | ||
| Classification of daily and near-daily headaches: field trial of revised IHS criteria | Q71656653 | ||
| Prevalence and description of chronic daily headache in the general population in France | Q73087319 | ||
| Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine | Q73172384 | ||
| Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers | Q73247299 | ||
| Reliability of the migraine disability assessment score in a population-based sample of headache sufferers | Q77359989 | ||
| Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study | Q83314884 | ||
| P921 | main subject | headache | Q86 |
| disability | Q12131 | ||
| chronic headache | Q2495736 | ||
| P304 | page(s) | S71-6 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Neurological Sciences | Q15763262 |
| P1476 | title | Disability in chronic daily headache: state of the art and future directions | |
| P478 | volume | 32 Suppl 1 |
| Q45004221 | A 14-month study of change in disability and mood state in patients with chronic migraine associated to medication overuse. |
| Q30939882 | Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study |
| Q53109838 | Burden of migraine: international perspectives. |
| Q40896923 | Burden of migraine: what should we say more? |
| Q33911693 | Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management |
| Q50577415 | Disability and mood state in patients with episodic and chronic migraine associated to medication overuse. |
| Q38108474 | Disability and quality of life in headache: where we are now and where we are heading. |
| Q41905159 | Disability, ICF biopsychosocial model and burden of migraine |
| Q40321539 | Food insecurity and migraine in Canada |
| Q55392147 | Migraine: incorrect self-management for a disabling disease. |
| Q37624770 | Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up |
| Q38014282 | Peripheral neuromodulation in chronic migraine. |
| Q44071118 | The role of tyrosine metabolism in the pathogenesis of chronic migraine. |
| Q38773592 | Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial |
| Q45376934 | Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse |
| Q58755897 | Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire |
| Q39002028 | World Health Organization disability assessment schedule 2.0: An international systematic review |
Search more.